| scholarly article | Q13442814 |
| P2093 | author name string | Carlos A Zarate | |
| J J Rasimas | |||
| Joshua J Griffiths | |||
| P2860 | cites work | Decrease in suicide among the individuals treated with antidepressants: a controlled study of antidepressants in suicide, Sweden 1995-2005. | Q37394792 |
| Suicide in the absence of mental disorder? A review of psychological autopsy studies across countries | Q38009809 | ||
| Synaptic mechanisms underlying rapid antidepressant action of ketamine | Q38093623 | ||
| Efficacy of risperidone augmentation to antidepressants in the management of suicidality in major depressive disorder: a randomized, double-blind, placebo-controlled pilot study | Q38388245 | ||
| A meta-analysis of neuropsychological markers of vulnerability to suicidal behavior in mood disorders | Q38444943 | ||
| A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department | Q42600332 | ||
| The role of psychopharmacology in suicide prevention | Q43208239 | ||
| Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. | Q43292973 | ||
| Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). | Q44268852 | ||
| Psychiatrists' attitude towards and knowledge of clozapine treatment | Q46150844 | ||
| Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomised, placebo-controlled, 1-year trial | Q46353446 | ||
| Suicide prevention by lithium SUPLI--challenges of a multi-center prospective study | Q46615999 | ||
| Reduction by paroxetine of suicidal behavior in patients with repeated suicide attempts but not major depression | Q47349654 | ||
| Clozapine markedly elevates pregnenolone in rat hippocampus, cerebral cortex, and serum: candidate mechanism for superior efficacy? | Q48424732 | ||
| Differential pattern of response in mood symptoms and suicide risk measures in severely ill depressed patients assigned to citalopram with placebo or citalopram combined with lithium: role of lithium levels | Q48828168 | ||
| Toward a clinical model of suicidal behavior in psychiatric patients. | Q50532711 | ||
| Standardization, integration, and sharing-leveraging research investments. | Q50798443 | ||
| Leading causes of unintentional and intentional injury mortality: United States, 2000-2009. | Q55558496 | ||
| Compliance with refilling prescriptions for atypical antipsychotic agents and its association with the risks for hospitalization, suicide, and death in patients with Schizophrenia in Quebec and Saskatchewan: A retrospective database study | Q57589554 | ||
| Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis | Q22242068 | ||
| Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial | Q24629398 | ||
| Transcranial direct current stimulation in severe, drug-resistant major depression | Q28238164 | ||
| Antidepressant effects of ketamine in depressed patients | Q29617327 | ||
| A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression | Q29617914 | ||
| GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effects | Q30440925 | ||
| Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data | Q30925583 | ||
| Analysis of Suicidality in Pooled Data From 2 Double-Blind, Placebo-Controlled Aripiprazole Adjunctive Therapy Trials in Major Depressive Disorder | Q33684142 | ||
| Mental disorders, comorbidity and suicidal behavior: results from the National Comorbidity Survey Replication | Q33926824 | ||
| Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice? | Q34116380 | ||
| A randomized trial of a low-trapping nonselective N-methyl-D-aspartate channel blocker in major depression | Q34315128 | ||
| Intracellular modulation of NMDA receptor function by antipsychotic drugs | Q34372226 | ||
| Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder | Q34451408 | ||
| Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials | Q34456077 | ||
| Arguments for the specificity of the antisuicidal effect of lithium. | Q34514976 | ||
| Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review | Q34574031 | ||
| Lithium treatment reduces suicide risk in recurrent major depressive disorder | Q34612639 | ||
| CSF 5-HIAA, cortisol and DHEAS levels in suicide attempters | Q34648935 | ||
| Treatment-emergent suicidal ideation during 4 months of acute management of unipolar major depression with SSRI pharmacotherapy or interpersonal psychotherapy in a randomized clinical trial | Q34814994 | ||
| Psychological autopsy studies of suicide: a systematic review | Q35109958 | ||
| Pilot randomized clinical trial of an SSRI vs bupropion: effects on suicidal behavior, ideation, and mood in major depression | Q35679916 | ||
| Best practice elements of multilevel suicide prevention strategies: a review of systematic reviews | Q35835977 | ||
| Effects of chronic clozapine administration on markers of arachidonic acid cascade and synaptic integrity in rat brain | Q36338174 | ||
| Epidemiological data suggest antidepressants reduce suicide risk among depressives. | Q36834722 | ||
| Bipolar pharmacotherapy and suicidal behavior Part 3: impact of antipsychotics | Q36866378 | ||
| Connecting inflammation with glutamate agonism in suicidality. | Q36901111 | ||
| Treatment of suicide attempters with bipolar disorder: a randomized clinical trial comparing lithium and valproate in the prevention of suicidal behavior | Q37158292 | ||
| NEUROBIOLOGICAL ASPECTS OF SUICIDE AND SUICIDE ATTEMPTS IN BIPOLAR DISORDER. | Q37343344 | ||
| P433 | issue | 3 Suppl 2 | |
| P921 | main subject | suicide | Q10737 |
| suicide prevention | Q3298118 | ||
| P304 | page(s) | S195-203 | |
| P577 | publication date | 2014-09-01 | |
| P1433 | published in | American Journal of Preventive Medicine | Q4744265 |
| P1476 | title | Existing and novel biological therapeutics in suicide prevention | |
| P478 | volume | 47 |
| Q38383728 | Antisuicidal Response Following Ketamine Infusion Is Associated With Decreased Nighttime Wakefulness in Major Depressive Disorder and Bipolar Disorder. |
| Q39721458 | Benefits of a Secondary Prevention Program in Suicide |
| Q60492108 | Characterizing the course of suicidal ideation response to ketamine |
| Q92403507 | Clozapine in Treatment-Resistant Bipolar Disorder With Suicidality. Three Case Reports |
| Q93177074 | Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments |
| Q91600191 | Is Ketamine the New Wonder Drug for Treating Suicide? |
| Q38809056 | KETAMINE: A POTENTIAL RAPID-ACTING ANTISUICIDAL AGENT? |
| Q91304373 | Ketamine for acute suicidal ideation. An emergency department intervention: A randomized, double-blind, placebo-controlled, proof-of-concept trial |
| Q41489870 | Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial |
| Q99238196 | Post-Psychedelic Reductions in Experiential Avoidance Are Associated With Decreases in Depression Severity and Suicidal Ideation |
| Q30234967 | Psychiatric Emergencies: Assessing and Managing Suicidal Ideation |
| Q48063920 | SUICIDAL DEPRESSED PATIENTS RESPOND LESS WELL TO ANTIDEPRESSANTS IN THE SHORT TERM. |
| Q91411481 | Single and repeated ketamine infusions for reduction of suicidal ideation in treatment-resistant depression |
| Q39218986 | Sleep architecture parameters as a putative biomarker of suicidal ideation in treatment-resistant depression. |
| Q47402907 | The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis. |
| Q91669661 | The Impact of Ayahuasca on Suicidality: Results From a Randomized Controlled Trial |
| Q60920952 | The effects of ketamine on suicidality across various formulations and study settings |
| Q39005702 | Understanding epigenetic architecture of suicide neurobiology: A critical perspective |
Search more.